Ycg LLC Raises Stake in Colgate-Palmolive (NYSE:CL)

Ycg LLC boosted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.1% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 205,178 shares of the company’s stock after buying an additional 235 shares during the quarter. Colgate-Palmolive accounts for about 1.6% of Ycg LLC’s portfolio, making the stock its 24th largest holding. Ycg LLC’s holdings in Colgate-Palmolive were worth $19,910,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Main Street Research LLC grew its holdings in shares of Colgate-Palmolive by 1.5% during the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock worth $673,000 after purchasing an additional 100 shares during the last quarter. Advisor OS LLC lifted its stake in Colgate-Palmolive by 4.5% in the second quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock valued at $228,000 after buying an additional 101 shares during the last quarter. BLB&B Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 2.5% in the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after acquiring an additional 104 shares during the period. ZWJ Investment Counsel Inc. increased its holdings in shares of Colgate-Palmolive by 3.1% in the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock valued at $349,000 after acquiring an additional 109 shares during the period. Finally, Hexagon Capital Partners LLC grew its position in Colgate-Palmolive by 9.5% during the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock worth $124,000 after purchasing an additional 110 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Citigroup upped their target price on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Evercore ISI lifted their target price on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. TD Cowen upped their price target on Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. Bank of America increased their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Finally, Morgan Stanley upped their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. Eight investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $102.53.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded down $0.67 during trading on Friday, hitting $107.86. 3,937,393 shares of the company were exchanged, compared to its average volume of 4,328,661. The firm has a 50 day moving average price of $101.07 and a 200 day moving average price of $94.52. The stock has a market capitalization of $88.49 billion, a price-to-earnings ratio of 34.13, a P/E/G ratio of 3.73 and a beta of 0.40. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same period in the prior year, the business earned $0.77 earnings per share. The business’s revenue was up 4.9% on a year-over-year basis. On average, equities analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date of this dividend was Friday, July 19th. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Colgate-Palmolive news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares in the company, valued at approximately $1,069,868.70. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 43,490 shares of company stock valued at $4,486,063. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.